Trial intelligence / Profile preview

Diagnostic Study of Coronary Microvascular Dysfunction in Women

NCT03537586Active, not recruiting

Sponsor
NYU Langone Health
Start
Jun 2018
Primary completion
Jun 2025
Countries
1
01

Overview

Open-label, single-arm trial, sponsored by NYU Langone Health. Primary endpoints: Platelet Activity measured by the Index of Microcirculatory Resistance (IMR) at 12 months and Measure of Inflammation measured by the Index of Microcirculatory Resistance (IMR) at 12 months. Started Jun 2018; status: active, not recruiting.

Beyond the preview

Go deeper on NCT03537586.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03537586.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call